Electromed, Inc. (ELMD): Price and Financial Metrics


Electromed, Inc. (ELMD): $10.80

-0.21 (-1.91%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

ELMD POWR Grades


  • ELMD scores best on the Quality dimension, with a Quality rank ahead of 95.51% of US stocks.
  • ELMD's strongest trending metric is Stability; it's been moving up over the last 48 weeks.
  • ELMD ranks lowest in Momentum; there it ranks in the 51st percentile.

ELMD Stock Summary

  • With a market capitalization of $92,438,377, Electromed Inc has a greater market value than just 12.61% of US stocks.
  • The ratio of debt to operating expenses for Electromed Inc is higher than it is for about merely 0.4% of US stocks.
  • ELMD's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of merely 8.95% of US stocks.
  • If you're looking for stocks that are quantitatively similar to Electromed Inc, a group of peers worth examining would be PESI, AOUT, VSTO, OESX, and TRT.
  • Visit ELMD's SEC page to see the company's official filings. To visit the company's web site, go to www.smartvest.com.

ELMD Valuation Summary

  • In comparison to the median Healthcare stock, ELMD's price/earnings ratio is 23.29% higher, now standing at 45.
  • Over the past 135 months, ELMD's price/sales ratio has gone up 0.7.
  • Over the past 135 months, ELMD's price/sales ratio has gone up 0.7.

Below are key valuation metrics over time for ELMD.

Stock Date P/S P/B P/E EV/EBIT
ELMD 2021-08-31 3.0 3.3 45.0 29.8
ELMD 2021-08-30 3.0 3.3 44.7 29.6
ELMD 2021-08-27 2.8 3.1 42.7 28.1
ELMD 2021-08-26 2.8 3.1 43.0 28.3
ELMD 2021-08-25 2.8 3.1 41.9 27.5
ELMD 2021-08-24 2.9 3.2 44.0 29.0

ELMD Growth Metrics

  • Its 4 year net income to common stockholders growth rate is now at 84.94%.
  • Its 2 year net cashflow from operations growth rate is now at 91.86%.
  • The 4 year net cashflow from operations growth rate now stands at 65.25%.
ELMD's revenue has moved up $5,136,412 over the prior 30 months.

The table below shows ELMD's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-06-30 35.756 3.077 2.362
2021-03-31 33.16457 3.608987 3.271013
2020-12-31 33.12149 3.663728 3.700516
2020-09-30 32.17236 4.389356 3.682145
2020-06-30 32.47069 4.196448 4.161439
2020-03-31 34.19694 4.330214 3.93983

ELMD's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • ELMD has a Quality Grade of A, ranking ahead of 95.51% of graded US stocks.
  • ELMD's asset turnover comes in at 0.99 -- ranking 21st of 183 Medical Equipment stocks.
  • DYNT, SYK, and IRMD are the stocks whose asset turnover ratios are most correlated with ELMD.

The table below shows ELMD's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.990 0.764 0.161
2021-03-31 0.943 0.783 0.196
2020-12-31 0.971 0.781 0.234
2020-09-30 0.974 0.777 0.239
2020-06-30 1.015 0.776 0.279
2020-03-31 1.102 0.768 0.301

ELMD Stock Price Chart Interactive Chart >

Price chart for ELMD

ELMD Price/Volume Stats

Current price $10.80 52-week high $13.85
Prev. close $11.01 52-week low $8.11
Day low $10.80 Volume 10,000
Day high $11.05 Avg. volume 52,089
50-day MA $11.88 Dividend yield N/A
200-day MA $11.04 Market Cap 92.55M

Electromed, Inc. (ELMD) Company Bio


Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of all ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology with personalized HFCWO therapy management portal for patients with compromised pulmonary function. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products primarily to home health care market for patients with bronchiectasis, cystic fibrosis, and neuromuscular disease. Electromed, Inc. markets its products primarily to physicians and health care providers, as well as directly to patients. The company was founded in 1992 and is headquartered in New Prague, Minnesota.


ELMD Latest News Stream


Event/Time News Detail
Loading, please wait...

ELMD Latest Social Stream


Loading social stream, please wait...

View Full ELMD Social Stream

Latest ELMD News From Around the Web

Below are the latest news stories about Electromed Inc that investors may wish to consider to help them evaluate ELMD as an investment opportunity.

Electromed, Inc. to Participate in the 2021 Colliers Institutional Investor Conference

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. (Electromed or the Company) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that Kathleen Skarvan, President and Chief Executive Officer, and Mike MacCourt, Chief Financial Officer, are scheduled to participate in the 2021 Colliers Institutional Investor Conference, which will be held virtually, on Thursday, September 9, 2021. About Electromed, Inc. Electromed manufactures, markets, and sells p

Business Wire | August 31, 2021

Electromed Reports Mixed Q4 Results, Provides Strategic Update

Electromed, Inc. (ELMD) reported mixed fiscal Q4 results, topping earnings estimates but falling a little short of revenue expectations. COVID-19-induced disruptions to patient visits and sales representative access across the industry impacted the results during the quarter. Shares of the manufacturer and seller of medical equipment, including the SmartVest Airway Clearance System, which provides airway clearance therapy to patients with compromised pulmonary function, have gained 24% year-to-date. (See Electromed stock charts on TipRanks) Adjusted earnings of $0.04 per were a cent ahead of analysts’ expectations of $0.03 per share. The company reported earnings of $0.15 per share in the prior-year period. Markedly, revenues jumped 37.7% year-over-year to $9.

Devina Lohia on TipRanks | August 25, 2021

Electromed, Inc. Announces Fiscal 2021 Fourth Quarter and Full Year Financial Results

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. (Electromed or the Company) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months (Q4 FY 2021) and full year (FY 2021) ended June 30, 2021. Q4 FY 2021 Financial Highlights Net revenue increased 37.7% to $9.5 million, from $6.9 million for the three months ended June 30, 2020 (Q4 FY 2020), driven by 33.6% home care revenue growth and 90.6% growth in institu

Business Wire | August 24, 2021

Electromed, Inc. Schedules its Fourth Quarter Fiscal 2021 Financial Results Conference Call for August 24, 2021 at 5:00 p.m. ET

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. (Electromed or the Company) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2021 fourth quarter ended June 30, 2021, on Tuesday, August 24, 2021 after the close of the stock market and host a conference call the same day at 5:00 p.m. Eastern Time to discuss the results. Interested parties may participate in the call by dialin

Business Wire | August 16, 2021

Electromed, Inc. to Consider Director Nominations from Summers Value Partners

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. (Electromed or the Company) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today confirmed that Summers Value Partners has provided notice of its intent to nominate four candidates to stand for election to the Electromed Board of Directors at its Fiscal 2022 Annual Meeting of Shareholders (the Annual Meeting). Members of Electromeds Board and management team have been engaged in an ongoing dialogue with Su

Business Wire | August 13, 2021

Read More 'ELMD' Stories Here

ELMD Price Returns

1-mo -13.04%
3-mo -10.00%
6-mo 7.57%
1-year 16.76%
3-year 72.25%
5-year 142.15%
YTD 10.09%
2020 13.41%
2019 69.94%
2018 -16.14%
2017 56.44%
2016 104.21%

Continue Researching ELMD

Want to see what other sources are saying about Electromed Inc's financials and stock price? Try the links below:

Electromed Inc (ELMD) Stock Price | Nasdaq
Electromed Inc (ELMD) Stock Quote, History and News - Yahoo Finance
Electromed Inc (ELMD) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.9775 seconds.